Hypothesis: What is the Best We Can Do with Hydroxychloroquine for COVID-19?

There are widespread anecdotal reports of seemingly successful treatment among the early (three to seven days from symptoms) stage coronavirus disease 2019 (COVID-19) patients with the drug hydroxychloroquine (HCQ), and randomized placebo-controlled trials of HCQ in outpatient settings are underway....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuncong, Mulier, Stefaan, Jonscher, Charles, Ye, Sheng, Chen, Lei, Feng, Yuanbo, Li, Yue, Ni, Yicheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585824/
https://www.ncbi.nlm.nih.gov/pubmed/33116907
http://dx.doi.org/10.2147/CLEP.S277889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585824/
https://www.ncbi.nlm.nih.gov/pubmed/33116907
http://dx.doi.org/10.2147/CLEP.S277889

Ejemplares similares